WHO WE ARE
Creative Medical Technology Holdings, Inc.
Ticker Symbol CELZ
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company committed to improving patient lives in the areas of Urology, Neurology and Orthopedics.
Since 2011, Creative Medical Technology Holdings, Inc. (CELZ) and our affiliate company Creative Medical Health, Inc. have focused on regenerative medical solutions for unmet Urological, Neurological and Orthopedic needs. We have developed an extensive intellectual property portfolio utilizing stem cells for the treatment of multiple indications and commercialized complete patented and trademarked protocols for erectile dysfunction under the CaverStem® brand and the FemCelz® brand for the treatment of female sexual dysfunction. Our StemSpine® technology will be launched in the near future. CELZ is also breaking new ground with its AmnioStem™ technology for the treatment of strokes, utilizing our patented amniotic fluid-based stem cell. Our team consists of leading international physicians and scientists specializing in regenerative medicine. Our “science-first” approach to procedures ensures that all of our technology are proven to be both safe and effective.
The Creative Medical Technology Holdings Difference
Commercialized Procedures (CaverStem® and FemCelz®)
Extensive Patent Portfolio
Key Relationships With Leading Scientists and Physicians
Validated Safety and Efficacy
Creative Medical Technology Holdings has developed/acquired a robust intellectual property (IP) portfolio related to the utilization of stem cells to improve patient lives in the areas of Urology, Neurology and Orthopedics.
This IP portfolio positions us at the forefront of the regenerative medicine industry (set to grow to $39Bn by 2023). We plan to commercialize these products on our own and in collaboration with strategic partners.
|Urology||US20170290887A1||Cell Based Therapy for Female Sexual Dysfunction|
|Urology||US20180015127A1||Methods for Treatment of Premature Ovarian Failure and Ovarian Aging Using Regenerative Cells|
|Urology||US20170354686A1||Adipose Derived Immunomodulatory Cells for Immunotherapy of Recurrent Spontaneous Abortions|
|Urology||US8372797B2||Treatment of Erectile Dysfunction by Stem Cell Therapy|
|Urology||US20180325959A1||Methods of Treating Erectile Dysfunction Using Regenerative Cells and Therapeutic Energy Treatments|
|Urology||US20180334664A1||Regeneration of Corpus Cavernosal Tissue|
|Neurology||US20180071342A1||Inducing and accelerating post-stroke recovery by administration of amniotic fluid derived stem cells|
|Neuro/Oncology||US20190022147A1||Treatment of Glioma by Amniotic Fluid Stem Cells and Exosomes Derived Thereof|
|Neurology||US20180340145A1||Generation of Autologous Immune Modulatory Cells for Treatment of Neurological Conditions|
|Neurology||US20180133258A1||Treatment of Cachexia Using Stem Cells and Products Thereof|
|Stem Cells||US7569385B2||Multipotent Amniotic Fetal Stem Cells|
|Orthopedics||US20180344899A1||Enhancement of Nucleus Pulposus Regeneration by Enhanced Perfusion of Perispinal Area by Combination Drug, Gene and Cellular Therapies|
|Orthopedics||US20180360882A1||Perispinal Perfusion by Administration of T Regulatory Cells Alone or in Combination with Angiogenic Cell Therapies|
|Orthopedics||US9598673B2||Treatment of Disc Degenerative Disease|
Chief Executive Officer
Chief Financial Officer
Thomas Ichim PhD
Chief Scientific Officer
Thomas Ichim PhD
Amit Patel MS MD
Timothy Henry MD
Director of Cardiology, Cedars-Sinai Heart Institute. Dr. Henry’s experience also includes Director of Research at Minneapolis Heart Institute Foundation.
Eric Duckers MD PhD
Assistant Professor, Erasmus Medical Center, Head, Molecular Cardiology Laboratory, Erasmus Medical Center and Interventional Cardiologist, Erasmus Medical Center, Rotterdam, Netherlands.
Santosh Kesari, MD, PhD
Director, Neuro-oncology; Chair and Professor, Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute
Amit Patel MS MD
Cardiac surgeon, former Associate
Professor and Director of Clinical
Regenerative Medicine and Tissue
Engineering at the University of Utah.
Dr. Patel has pioneered break-through therapies using stem cells and is a world leader in stem cell therapies.
Regenerative Stem Cell Procedure for Treatment of Erectile Dysfunction in Men
Regenerative Stem Cell Procedure for Treatment of Female Sexual Dysfunction
Regenerative Stem Cell Procedure for Treatment of Degenerative Disc Disease
Amniotic Fluid Derived Stem Cells for Treatment of Stroke
At Creative Medical Technology Holdings, our team is committed to unlocking the full potential of regenerative medicine to improve human health.
We are always looking for talented individuals to join us in this mission.
To be considered, please email your resume to